NYSE:LHHealthcare
Should Labcorp’s AI Pathology Push and Buybacks Recast the Long-Term Story for Labcorp (LH) Investors?
In February 2026, Labcorp Holdings reported fourth-quarter 2025 sales of US$3,515.8 million and net income of US$164.7 million, issued 2026 revenue guidance of US$14.61–14.79 billion, and confirmed completion of a multi-year US$3,640.51 million share repurchase program.
At the same time, Labcorp expanded its AI-enabled digital pathology collaboration with PathAI, signaling a deeper push into technology-driven diagnostics alongside its earnings update.
Now we’ll examine how the reaffirmed...